Novel p2x7 epitopes
作者： Angus Gidley-Baird , Julian Alexander Barden
DOI:
关键词:
摘要: The invention relates to purinergic (P2X) receptors, more specifically P2X7 the generation of antibodies and use immunogens that are capable selectively binding a non ATP-binding receptor but not an receptor, for detection treatment disease conditions, especially cancer.
lens.org 参考文章(24)
Angus Gidley-Baird, Julian Alexander Barden, Anti-p2x7 peptiden und epitopen ,(2009)
Reiner L. Gentz, Steven M. Ruben, Y. Eric Shi, Jian Ni, Pancreas-derived plasminogen activator inhibitor ,(2001)
Alfonso R. Gennaro, Remington: The Science and Practice of Pharmacy ,(2003)
Angus Gidley-Baird, Julian Alexander Barden, Antibodies against non functional p2x7 receptor ,(2007)
Michael Slater, Julian Barden, A method for identifying pre-neoplastic and/or neoplastic states in mammals ,(2000)
Paul J Sheskey, Marian E Quinn, Raymond C Rowe, Handbook of Pharmaceutical Excipients ,(1994)
Angus Gidley-Baird, Julian Alexander Barden, Hybridomas producing antibodies against non functional p2x7 receptor ,(2007)
Inge Sillaber, Marcelo Paez-Pereda, Nicholas Barden, Means and methods for diagnosing and treating affective disorders ,(2004)
George Gorodeski, Xin Li, Ying-Hong Feng, Truncated proteins as cancer markers ,(2007)
Angus Gidley-Baird, Julian Alexander Barden, Antibodies to non-functional p2x7 receptor diagnosis and treatment of cancers and other conditions ,(2002)